Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
26.3%
% of OZEM's 21 holdings also in MEDX
16.7%
% of MEDX's 30 holdings also in OZEM
Overlap by Weight
Sector Drift (OZEM minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.4% | 17.3% | 14.4% |
|
PFIZER INC | 3.4% | 3.9% | 3.4% |
 |
ASTRAZENECA PLC-SPONS ADR | 3.3% | 5.7% | 3.3% |
|
AMGEN INC | 3.1% | 5.9% | 3.1% |
|
REGENERON PHARMACEUTICALS | 2.3% | 2.7% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
OZEM Overweight Relative to MEDX
 |
NOVO-NORDISK A/S-SPONS ADR | 19.4% |
|
ZEALAND PHARMA A/S | 5.4% |
 |
ROCHE HOLDING LTD | 5.0% |
|
VIKING THERAPEUTICS, INC. | 4.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 4.0% |
|
ALTIMMUNE, INC. | 3.8% |
 |
INNOVENT BIOLOGICS, INC. | 3.8% |
 |
HANMI PHARM CO LTD | 3.1% |
|
TERNS PHARMACEUTICALS, INC. | 3.1% |
|
SCHOLAR ROCK HOLDING CORP. | 2.0% |
OZEM Underweight Relative to MEDX
|
ABBVIE INC | -9.5% |
|
NOVARTIS AG-ADR | -6.9% |
|
BRISTOL-MYERS SQUIBB CO | -5.6% |
|
JOHNSON & JOHNSON | -5.0% |
|
ALNYLAM PHARMACEUTICALS INC | -4.7% |
 |
ALKERMES PLC | -4.6% |
|
MERCK & CO. INC. | -3.5% |
|
ELI LILLY & CO | -2.9% |
|
AMGEN INC | -2.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.8% |